Kendle has opened a new office in Ann Arbor, MI, expanding its Phase II-IV clinical development services for its biopharmaceutical customers. The new office also creates opportunities for the region.

“With the University of Michigan nearby, Ann Arbor as a region is increasing its commitment to become a hub of biotech activity,” said Kendle’s senior vice president, global clinical development, North America, Martha Feller, Ph.D. “Building on a year in which we experienced significant growth, this new office will allow us to hire extremely qualified employees who are able to serve our customers immediately. In fact, our ability to attract and retain clinical research professionals is part of what separates Kendle from other CROs.”

Frank Lobeck, Pharm.D., and Mel Kropko, MS will provide leadership for the new clinical project management office. Both are directors, global clinical development, North America, responsible for overseeing the activities of recently hired clinical research professionals. Prior to joining the company, Mr. Lobeck and Mr. Kropko worked with Pfizer, Inc., where they led and managed the operational aspects of international clinical research studies.